email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
2116 - 2130
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Peijia Medical Raises $100 Million for Medical Device Development
$5.00
Available
Ark Bio Reports Positive Results from Phase II Trial of Novel RSV Treatment
$5.00
Available
BeiGene Enters $160 Million Deal for Rights to Seattle Genetics Cancer Molecule
$5.00
Available
Genecast Closes $43 Million VC Funding for Cancer Diagnostics
$5.00
Available
Simcere In-Licenses China Rights to Clinical-Stage Stroke Treatment
$5.00
Available
CANbridge OK'd to Launch Breast Cancer Drug in Hong Kong
$5.00
Available
SinoMed, a Medical Device Company, Stages $50 Million IPO on the Shanghai STAR Exchange
$5.00
Available
Akeso Closes $150 Million Series D for Antibody Development
$5.00
Available
Harbour BioMed Starts Australian Trial of CTLA-4 Checkpoint Inhibitor
$5.00
Available
Ascentage and Henlius to Test Two-drug Combination in China Leukemia Trial
$5.00
Available
Shanghai Green Valley Surprises with China Approval for Alzheimer's Treatment
$5.00
Available
QYuns Out-Licenses Ex-China Rights for Autoimmune Portfolio to Seneca
$5.00
Available
Denovo Closes $43 Million B Round for Biomarker Driven Drug Development
$5.00
Available
I-Mab Files for $100 Million IPO on the NASDAQ Exchange
$5.00
Available
QnQuality Pharma Raises $15 Million for Oncotherapy Side-Effect Drugs
$5.00
Available